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Abstract 
Anti-malarial drugs are drugs used to treat or prevent malaria in endemic countries. The purpose of this work 
was aimed at analyzing the use of anti-malarial drugs on adult patients in Federal Medical Centre (FMC), 
Yenagoa. A systematic random sampling technique was used to select the sample size of 5230 patients’ folder 
from available records which consisted of 2458 and 2772 male and females respectively. An archival-descriptive 
research design was used which enabled the study obtained data from General Out Patient Department (GOPD). 
Data obtained were analyzed by using tables, bar chart, pie chart and chi-square statistical test. Four null 
hypotheses were tested at 0.05 alpha level of significance which HO1 was retained, while HO2, HO3, and HO4 
were rejected at df3 of critical X
2  
value of 7.815. Result from the analysis of sex ratio gave male-female ratio was 
89:100, indicating more females were treated however the difference was not significant. It was tested and 
observed that four different categories of anti-malarial drugs were used in the year 2012 and all the used anti-
malarial drugs showed side effects. Meanwhile, Artemisinin Combination Therapy was most frequently used in 
the health facilities. Based on the findings, conclusions were drawn  and recommendation were made that 
government, World Health Organization and other non-governmental agencies should  hasten the development 
of malaria vaccine and ACTs should be available at all times for the treatment of adult patients with malaria. 
Keywords: categorical data, antimalarial drugs, general out-patient department (GOPD), malaria. 
 
1. INTRODUCTION 
Malaria disease is an age long disease that has been in the medical literature for approximately 30 million years 
(Carter & Mendis, 2002). The name malaria was derived from ‘mal’ ‘aria’ meaning ‘bad air’. To Opeskin (2008), 
this meaning was borne out from the ancient Romans who thought that the disease came from the foul gases 
released from soil, water and air. Nevertheless, malaria has been noted as wide spread and potentially lethal 
infectious disease which has afflicted people for much of human history and affected settlement patterns in 
Africa, especially Nigeria. 
Fairhust and Wellems (2010) identified that malaria is caused by infection with sporozoa of the genus 
plasmodium, transmitted in nature by the bite of the female anopheles mosquito. In Nigeria, the authors 
emphasized that over three quarters of malaria infections is caused by plasmodium falciparium which is followed 
by plasmodium malaria and plasmodium ovale. This is to say that among the four species of plasmodium that 
cause malaria infection, plasmodium vivax is seldomely noticed. 
Consequently, malaria is a highly endemic disease in Nigeria and according to Hartman, Rogerson and 
Fischer (2010), it is one of the major cause of ill-health and deaths especially in children. However   several 
control measures have been developed to control spread of the disease. One of such measure is the use of anti-
malaria drugs but it has been observed that patients are still dying of the disease. What, then, is the anti-malaria 
drugs used in the treatment of malaria infection in this part of Nigeria. 
This, sturdy, therefore purposed to categorically analyse the use of anti-malaria drugs in adult patient 
treated in Federal Medical Centre, Yenagoa. The study was guided by the following questions. 
a. Which are the different categories of anti-malaria drugs used in the treatment of malaria infection in 
FMC for the year 2012? 
b. Which category of anti-malaria drug is frequently administrated in treating adult patient with malaria? 
There is no gain saying that available literatures identified several categories of anti-malaria drugs. 
Nayyar, Bremain, Newton and Hemington (2012) identified quinine as an anti-malaria drug but it is capable in 
causing hypoglycaemia through its action of stimulating insulin secretion. Until recently, chloroquine was the 
most widely used anti-malaria drug. Patricia (2008) posited that chloroquine is an aminoquinoline compound 
with an ampheated and still unclear mechanism of action. It has a significant antipyretic and anti-inflammatory 
effect when used to treat plasmodium vivax infections and thus if may still remain useful even when resistance is 
more wide spread (Patricia).  
The world health organization (WHO), (2010), in its guidelines revealed amodaquine in a combine 
formulation with alternate (ASAP). Amodiaquine is similar to chloroquine and effectively used in areas of 
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chloroquine retrotance while some patients prefer its tendency to cause less iteling than chloroquine.  
Another anti-malarial drug is pyrimethemine. This anti-malarial drug is used in the treatment of 
uncomplicated malaria.  
According to Ferri (2008), pyrimethanmine is only used in concert with a sulphonamide.  
Proquanil is a synthetic derivative of pyrimidine. It is useful in prophylatin when combined with atovaguone or 
chloroqunie (Ferri, 2008). Sulfonamudis, mefloquine, Atovaquine, primaquine, halofamtrine and Artenmisimin 
are other anti-malarial drugs used either alone or in combination with another for the treatment of malaria (WAI, 
2010). Current practice in treating malaria cases is now based on the concept of combination therapy (WHO, 
2010).  
This study observed that not all aforementioned anti-malarial drugs are used in Federal Medical Centre, 
Yenagoa.  
 
2. METHOD: 
The purpose of this study was to carry out a categorical data analysis on the use of anti-malarial drugs on adult 
patients in Federal Medical Centre, Yenagoa in the 2012. Specifically, thin study was to identify the sex ration of 
malaria attacks on adult patients, the categories of anti-malaria drugs used and the most frequently used anti-
malarial drug in Federal Medical Centre, Yenagoa. The study also tested the following hypothesis.  
 Anti-malarial drugs used in adult patients have no significant association among male and 
female. 
 Categories of anti-malaria drugs used in treatment of malaria in adult patients have no 
significance association.  
 Number of patients having side effects after taking anti-malarial drugs have no significance 
association.  
 Categories of anti-malarial drugs frequently administered have no significant association. 
The study adopted an archival/descriptive survey research designs which enabled the study randomly 
selected from available records, 5320 adult patients folders who were infected and treated malaria in FMC from 
January – December, 2012. A consisted of  2458 and 2772  male and female folders respectively. The data were 
gathered from the FMC, Yenagoa after gaining an ethical approval from the institution. The data were collected 
from the folders of selected patients with malaria. It was from the demographic section and treatment plan of the 
patient folder that all data were collected. This is shown in table 1. Categorical data were analysed with tables, 
bar chart and chi-square (X
2
) for the hypothesis at 0.05 level of significance.  
 
3. RESULTS: 
The results presented below are used to answer the research question and test the four null hypotheses at 0.05 
level of significance.  
Table 1. Number of adult patients treated of malaria by gender from January – December, 2012 in FMC 
Yenagoa  
 
MONTHS NUMBER OF PATIENTS GENDER 
MALE FEMALE 
JANUARY 295 135 160 
FEBRUARY 454 254 200 
MARCH 560 250 310 
APRIL 370 150 220 
MAY 381 189 192 
JUNE 519 280 239 
JULY 538 288 250 
AUGUST 557 235 322 
SEPTEMBER 227 77 150 
OCTOBER 519 235 284 
NOVEMBER 456 223 233 
DECEMBER 354 142 212 
TOTAL 5,230 2,485 2,772 
Table 1 show that more adult females were treated of malaria than males, resulting a sex ratio of 
approximately 89 males to 100 females. 
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Figure 1: A multiple bar chart representing categories of anti-malaria drugs used for multiple treatment of 
malaria 2012. 
 
Figure 1 depicts that ACT, Artequine, Quinine and S/P were different categories of anti-malaria drugs 
used in treating adult patients with malaria in   FMC, in the year 2012. The graph also shows that ACT was the 
most frequently used anti-malaria drugs in Federal Medical Centre, Yenagoa. Figure 1 also present use of 
antimalarial drugs by gender, indicating that female uses all categories of antimalarial drugs than males. 
 
 
Fig 2. Pie chart showing categories of anti-malarial drugs administration at FMC Yenagoa in 2012 
Figure 2 shows categories of antimalarial drugs administration at FMC, Yenagoa. This indicates that at 
FMC, Yenagoa ACT(60%) is most frequently administered than all other  categories  of malarial drugs while 
S/P(7%) is the less administered drug at FMC.  
 
Table 2. Summary of chi-square (X
2
) analysis for the four null hypotheses 
Ho Cal. X
2
 X
2 
– Critical Sp Level DF Decision 
1 0.00 7.82 0.05 3 Retain Ho  
2 78.34   3 Reject Ho 
3 41.8   3 Reject Ho 
4 78.34   3 Reject Ho 
Table 2 showed a calculated chi-square value of 0.00, 78.34, 41.8, and 78.34 with 3 degrees of freedom and 
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a critical value of x
2
 value of 7.82. The cal. x
2
 for the Ho is less than the critical x
2
 at 0.05 chosen alpha hence 
the association is not significant. The conclusion here would be that the categories of anti malaria drugs used in 
treating adult patients have no significant association among male and females. HO2, HO3, and HO4 were all 
rejected at 0.05 alpha levels. This implies that association of anti-malaria use is highly significant. The number 
of patients having side effects after using categories of anti malaria drugs has a significant association.  
 
4. Discussion 
From the result of this study, it has been observed that nearly four categories of anti malaria drugs are frequently 
used at Federal Medical Centre, Yenagoa in the year 2012. Artemisinin combination therapy(ACT), Adequine, 
Quinine and sulfadorcine/pryrimethamine (s/p). Figure1 shows the monthly usage of the drug which indicates 
that ACT was the most frequently used drug. This finding is in line with (WHO,2012). The table 1 showed that 
in  the month of March, August, July, June and October the number of malaria patients that visited the centre 
was high (150, 557,538, 519, & 519 respectively) why the month of September was the least (227). It has been 
on record that malaria risk is highest from October to May in South Africa (MD travel health.com, 2013). In this 
study it was revealed that more females were treated of malaria with the categories of anti-malaria drugs than 
males; having sex ratio 89:100 (Males: Females). The hypothesis of no association of treatment of malaria 
among gender with anti-malaria drugs was not significant. Therefore the ratio difference of 11 is not a significant 
value. This implies that malaria treatment of male is independent of female in the use of anti-malaria drugs. The 
sturdy finding   does not regard the observation of information on malaria  (2012). It was observed that malaria 
infection on pregnant women may be more severe than in non pregnant women who determine the selection of 
anti- malaria drugs to be given to avoid possible adverse effect. 
From the findings the study observed that the use of anti-malaria drugs have significant association, 
meaning usage was not independent to one another. Similarly, the anti-malaria drugs ability to give side effects 
to users was not significant. Available literatures reveal that many of the side effects of malaria medication are 
less pronounced when the medication is taken with meals. In general, the side effects of anti-malaria drugs are 
very similar (www.echo.com). Also, Nayyar, Breman, Newton and Herrington (2012) supported the findings that 
Quinine has the highest level of side effects on patients but it is characterized by most common symptoms. 
Opeskin (2008) stated that there is a need for prompt and concerted action on malaria at the National, regional 
and International levels if the public health concerns arising from the disease are to be adequately addressed. 
Artemisinin based combination therapy (ACT) is the first line treatment for uncomplicated falciparium malaria. 
Use of ACT has shown success in this preventable and treatable disease but resistance is emerging creating the 
need for new therapies, remarked Nosten et al. (2012). This is in agreement with the findings of the study. 
 
5. Conclusion 
The sturdy concludes that at Federal Medical Centre Yenagoa, four categories of anti-malaria drugs were used to 
treat adult patients with malaria infection in the year 2012. All the anti-malaria drugs prescribed indicated 
predisposed patients in having side effects. The study also concludes that females use more of prescribed anti-
malaria drugs male counter parts. 
 
6. Recommendation 
Base on the findings and conclusions drawn the following recommendations were made.viz;  
 World Health Organization and other non-governmental organization should support the 
formulation of vaccine to enhance possible malaria eradication programmes. 
 Hospitals should follow World Health Organization guideline in Malaria treatment to avoid 
undesirable risk to patient.  
 Government and non-governmental organizations and international health agencies should take 
more proactive measures to reduce the rate of infection of malaria in adult patients. 
 ACTs should be made available at all times for the treatment of adult malaria. 
 More effective anti malarial drugs should be used to complement the use of ACTs for the 
treatment of malaria. 
 
References 
Carter R. & Mendis K.N.(2002). Evolutionary and historical aspect of  malaria.clinical microbiological review. 
15 (4): 564-594. Retrived from:   http://skihore.wikispaces.com/file/view/Evo-Historical+malaria.pdf 
Fairhust R.M & Wellems T.(2010). Plasmodium species (malaria). In: Mandel  G diseases (7
th
.L, Bennett J.E, 
Dolin R. (eds). Principles and practice of  infectious ed.). pp.3437-3462.U.S.A: Churchill Livingstone.     
Ferri F.F (2008). Protozoal infections. Ferri’s color atlas of clinical medicine.  p.1159. saunders Information on 
malaria (2013). Retrieved from:  http://www.doctortravel.ca/index.php?page=malaria. 
MDtravel health.com(2013). Retrieved from: http://www.ehow.com/about5052862-sideeffect-malaria-
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.4, No.18, 2014 
 
87 
medicine.html. 
Nayyer G.M.L., Breman J.G., Newton P.N., & Herrington J. (2012). Poor quality anti-malarial drugs in South 
East Asia and sub-Saharan Africa. Retrieved  from www.the lancets.com/journals/laninf/article/PIIS 
1473-3099(12) 70064-6. 
Nosten F., White N.J, McGready R., Boel M.E., Poespoprodjo R., Singh N.,  Syafruddin D., & Rogerson S. 
(2012). A review article on synrian India’s first  antimalarial drug. p.4. pharmatutor Edu Labs. 
Peskin B.R. (2009). Malaria in pacific population: seen but not heard, Journal of   Population Research. 
26(2):175-199. 
Schagenhauf-Lawlow P. (2008). Travelers malaria.pmph U.S.A ltd series. PMPH- USA. 
World Health Organization  (2010). Guidlines for the treatment of malaria (2
nd
  ed.).p.194. retrieved from 
        www.who.int/malaria/publication/ato3/9789241547925/en/index.html 
 
 
   
  
The IISTE is a pioneer in the Open-Access hosting service and academic event 
management.  The aim of the firm is Accelerating Global Knowledge Sharing. 
 
More information about the firm can be found on the homepage:  
http://www.iiste.org 
 
CALL FOR JOURNAL PAPERS 
There are more than 30 peer-reviewed academic journals hosted under the hosting 
platform.   
Prospective authors of journals can find the submission instruction on the 
following page: http://www.iiste.org/journals/  All the journals articles are available 
online to the readers all over the world without financial, legal, or technical barriers 
other than those inseparable from gaining access to the internet itself.  Paper version 
of the journals is also available upon request of readers and authors.  
 
MORE RESOURCES 
Book publication information: http://www.iiste.org/book/ 
 
IISTE Knowledge Sharing Partners 
EBSCO, Index Copernicus, Ulrich's Periodicals Directory, JournalTOCS, PKP Open 
Archives Harvester, Bielefeld Academic Search Engine, Elektronische 
Zeitschriftenbibliothek EZB, Open J-Gate, OCLC WorldCat, Universe Digtial 
Library , NewJour, Google Scholar 
 
 
